Members of Ismagilov Group have backgrounds in chemistry, biology, engineering, medicine, and biophysics—creating a rich, interdisciplinary environment in which to solve real-world problems. Uniting the group's diverse interests is a commitment to improve global health, specifically via their work on the human microbiome and in vitro diagnostics. The lab has responded to the COVID-19 pandemic by launching a community-based transmission study in collaboration with the Pasadena Public Health Department: https://covid-study.caltech.edu/
Ismagilov Lab has pioneered the development of microfluidic technologies (including SlipChip and droplet-based microfluidics for chemical and biological reactions). Microfluidics enables ultrasensitive, quantitative biomarker measurements, and provides tools with which to control and understand the dynamics of complex chemical and biological networks. Droplet-based microfluidics is now used ubiquitously for single-molecule and single-cell analyses.
Several examples of projects are described below; for additional information please see our Publications
[click on the images to learn more]
FOR GLOBAL HEALTH
We are currently hiring postdoctoral researchers in all three of the above areas. Please see our "Positions" page for more details.